You are viewing the site in preview mode
Skip to main content
| |
DM n (%) (N = 71)
|
PM n (%) (N = 20)
|
p(DM vs. PM)
|
|---|
|
Serologic group
| | | |
|
MSA (anti-Jo-1)
|
1 (1.4)
|
2 (10)
|
0.06
|
|
MAA (SSA, SSB or Scl)
|
4 (5.63)
|
4 (20)
|
0.05
|
|
Clinical presentations
| | | |
|
Fever
|
4 (5.6)
|
1 (5)
|
0.92
|
|
Raynaud’s disease
|
0.00
|
1 (5)
|
0.06
|
|
Arthritis
|
1 (1.4)
|
0.00
|
0.59
|
|
Interstitial lung disease
|
261 (37.7)
|
132 (76.5)
|
0.04
|
|
Palpitations
|
1 (1.4)
|
0.00
|
0.59
|
|
Dysphagia
|
10 (14.1)
|
4 (20)
|
0.51
|
|
V-sign
|
26 (36.6)
|
0.00
|
n/a
|
|
Gottron papules
|
24 (33.8)
|
0.00
|
n/a
|
|
Periorbital edematous rash
|
11 (15.5)
|
0.00
|
n/a
|
|
Shawl sign
|
13 (18.3)
|
0.00
|
n/a
|
|
Cuticular overgrowth
|
3 (4.2)
|
0.00
|
n/a
|
- MSA: myositosis-specific autoantiboides; MAA: myositosis associated autoantibodies;
-
169 DM patients evaluated; 217 PM patients evaluated; n/a: not applicable.
